耳学和神经病学临床试验:科学现状
Lindsay S Moore1, Varun Sagi1, Konstantina M Stankovic1,2,3
1Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Stanford, CA, United States.
Frontiers in neurology
|August 8, 2025
概括
耳科和神经病科的干预性临床试验显示,近年来耳科和神经病科的增长停滞不前. 对于听力损失和前置神经瘤的新兴疗法提供了未来的研究机会.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 神经外科 神经外科
- 临床研究 临床研究
背景情况:
- 干预性临床试验对于推进耳科和神经病学至关重要.
- 了解试验活动当前的趋势和差距对于未来的研究和治疗开发至关重要.
研究的目的:
- 评估目前耳学和神经病学干预性临床试验的现状.
- 确定这一领域的趋势,重点领域和新兴的治疗途径.
主要方法:
- 从2019年1月1日到2025年5月31日,在ClinicalTrials.gov上注册的干预性耳科/神经学临床试验的综合审查.
- 数据收集包括试验状态,阶段,设计,参与者,干预类型,资金和结果状态.
主要成果:
- 虽然整体试验数量在过去15年里有所增长,但最近的增长却停滞不前.
- 听力损失试验占主导地位,通常使用设备和随机化,非工业/政府资助.
- 趋势显示,对于前体障碍的设备/程序干预和对声的行为干预,趋势正在转向设备/程序干预.
结论:
- 尽管停滞不前,新兴领域,如基因和药物治疗听力损失和前置神经瘤,提供有前途的途径.
- 持续监测临床试验趋势对于确定创新机会和确保健康的研究环境至关重要.
更多相关视频
10:27In Vivo Morphometric Analysis of Human Cranial Nerves Using Magnetic Resonance Imaging in Menière's Disease Ears and Normal Hearing Ears
Published on: February 21, 2018
10.7K
04:32Sound Source Localization Testing in Single-sided Deafness Following Bone Conduction Intervention
Published on: December 20, 2024
434
相关概念视频
Clinical Trials
8.4K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.4K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
